Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nau

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|August 4, 1998
Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomyR Nau, C Lassek, M Kinzig-Schippers, et al.
Medical Care|July 1, 1987
Appraisal of modifiable hospitalization risksF Alemi, J Stokes, J Rice, et al.
Acta Neurologica Scandinavica|October 1, 1996
Focal neurologic deficits in infective endocarditis and other septic diseasesA Bitsch, R Nau, R A Hilgers, et al.
Neurology|December 1, 1996
Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancyA Thiel, R Nau, F Fischer, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1995
Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitisR Nau, G Zysk, R R Reinert, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2007
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulationT P Lodise, R Nau, M Kinzig, et al.
Journal of Neurochemistry|September 1, 1986
Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of guinea pig small intestineR Nau, G Schäfer, C F Deacon, et al.
Brain : a Journal of Neurology|December 21, 2005
Neuropsychological sequelae of bacterial and viral meningitisH Schmidt, B Heimann, M Djukic, et al.
Neuroscience Letters|March 24, 1998
Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitisH Tumani, H Reiber, R Nau, et al.
Intensive Care Medicine|January 1, 1992
Results of four technical investigations in fifty clinically brain dead patientsR Nau, H W Prange, J Klingelhöfer, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|August 4, 1998
Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomyR Nau, C Lassek, M Kinzig-Schippers, et al.
Medical Care|July 1, 1987
Appraisal of modifiable hospitalization risksF Alemi, J Stokes, J Rice, et al.
Acta Neurologica Scandinavica|October 1, 1996
Focal neurologic deficits in infective endocarditis and other septic diseasesA Bitsch, R Nau, R A Hilgers, et al.
Neurology|December 1, 1996
Healthy infant delivered by a mother with subacute sclerosing panencephalitis during pregnancyA Thiel, R Nau, F Fischer, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1995
Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitisR Nau, G Zysk, R R Reinert, et al.
The Journal of Antimicrobial Chemotherapy|September 6, 2007
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulationT P Lodise, R Nau, M Kinzig, et al.
Journal of Neurochemistry|September 1, 1986
Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of guinea pig small intestineR Nau, G Schäfer, C F Deacon, et al.
Brain : a Journal of Neurology|December 21, 2005
Neuropsychological sequelae of bacterial and viral meningitisH Schmidt, B Heimann, M Djukic, et al.
Neuroscience Letters|March 24, 1998
Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitisH Tumani, H Reiber, R Nau, et al.
Intensive Care Medicine|January 1, 1992
Results of four technical investigations in fifty clinically brain dead patientsR Nau, H W Prange, J Klingelhöfer, et al.
Pageof 15